Order before 2:00 PM - your package will be shipped the same day!
Borrelia IgM antibodies are antibodies produced as part of an earlier immune response to Borrelia bacteria. IgM may be associated with more recent exposure, but antibody timing can vary, and early infection may not always produce detectable antibodies. Results should be interpreted together with clinical findings, timing of possible tick exposure and other relevant information.

IgM testing is important in the diagnosis of Lyme disease as it helps detect early infection. IgM antibodies to Borrelia burgdorferi typically appear within a few weeks of infection, making this test useful for identifying recent exposure to the tick-borne bacterium.
Individuals who have been bitten by a tick or have been in areas where Lyme disease is common and present with symptoms such as fever, rash (erythema migrans), fatigue, and joint pain should undergo IgM testing. Early detection is crucial for effective treatment.
Positive IgM results, especially when combined with symptoms and possible tick exposure, usually lead to prompt treatment with antibiotics. Early treatment is crucial to prevent the progression of Lyme disease to more severe stages that can affect the joints, heart, and nervous system.
False positives in IgM tests can occur due to cross-reactivity with other bacteria, previous infections, or certain autoimmune disorders. This is why positive results from an IgM test are usually confirmed with additional testing, such as the IgG antibody test or Western blot.
Lyme disease is caused by the Borrelia bacteria and is primarily transmitted through tick bites. It can lead to a range of symptoms, including fever, headache, fatigue, joint pain, and a characteristic skin rash called erythema migrans. The Lyme IgG/IgM Rapid Test detects early and past infections by analyzing for IgM and IgG antibodies in blood, offering rapid, reliable results.
₹ 1 800.00 INR
